From January 12, 2024 to January 15, 2024, the company has repurchased 160,000 shares, representing 0.93% for ¥303.36 million. With this, the company has completed the repurchase of 160,000 shares, representing 0.93% for ¥303.36 million under the buyback announced on January 12, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,542 JPY | +1.60% | +0.67% | +33.44% |
Apr. 12 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
Apr. 12 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.44% | 250M | |
+20.32% | 43.95B | |
+22.22% | 22.49B | |
+11.68% | 14.71B | |
+11.31% | 13.77B | |
+42.32% | 12.3B | |
-8.70% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.48B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 12, 2024.